Clinical Trials
25 trialsNCT06810336 2026-05-04
Pain Control and Quality of Recovery After Intravenous Methadone Versus Intravenous Remifentanil in Craniotomy Surgery
University of Virginia
Phase EARLY_PHASE1 Recruiting
NCT03574792 2026-04-16
Gabapentin, Methadone, and Oxycodone With or Without Venlafaxine Hydrochloride in Managing Pain in Participants With Stage II-IV Squamous Cell Head and Neck Cancer Undergoing Chemoradiation Therapy
Roswell Park Cancer Institute
Phase 2 Completed
NCT06525740 2026-03-04
Methadone Versus Intrathecal Hydromorphone for Postoperative Pain Relief in Gynecologic Cancer Undergoing Surgery
Mayo Clinic
Phase 4 Recruiting
NCT05417100 2026-01-27
Understanding How Methadone Treatment During Surgery Affects Pain Levels and the Need for Pain Medications After Surgery
Memorial Sloan Kettering Cancer Center
Phase 3 Active not recruiting
NCT06536517 2026-01-12
The Effects of One-time Intraoperative Methadone During Laparoscopic Hysterectomy in Reducing Opioid Prescription.
Johns Hopkins University
Phase 2 Recruiting
NCT07092475 2025-11-26
The Impact of Intraoperative Methadone on Postoperative Opioid Use
University of Utah
Phase 3 Withdrawn
NCT06940570 2025-10-23
MATCH
University of Texas Southwestern Medical Center
Phase 3 Suspended
NCT01793480 2024-10-31
EQUIMETH2
RECORDATI GROUP
Phase 3 Completed
NCT00930332 2024-02-12
Methadone Hydrochloride as First-Line Therapy in Treating Patients With Chronic Neuropathic Cancer Pain
Canadian Cancer Trials Group
Phase 1 Terminated
NCT04475029 2023-09-13
METAMORF
University of Aarhus
Phase NA Completed
NCT05251376 2023-01-19
Study of LYN-014 in Individuals With Opioid Use Disorder Who Are Stable on Methadone Therapy
Lyndra Inc.
Phase 1 Withdrawn
NCT05325164 2022-12-05
METHADOPT
Ottawa Hospital Research Institute
Phase 3 Withdrawn
NCT02531906 2022-07-25
Gabapentin, Methadone Hydrochloride, and Oxycodone Hydrochloride in Improving Quality of Life in Patients With Stage II-IV Head and Neck Cancer During Chemoradiation
Roswell Park Cancer Institute
Phase 1 Completed
NCT00726830 2020-09-24
Methadone, Morphine, or Oxycodone in Treating Pain in Patients With Cancer
M.D. Anderson Cancer Center
Phase NA Terminated
NCT03324815 2017-10-30
Methadone Associated With Morphine for Cancer Pain
Federal University of São Paulo
Phase NA Unknown
NCT00125294 2017-09-25
Sublingual Methadone for the Management of Cancer Breakthrough Pain
AHS Cancer Control Alberta
Phase 1 Completed
NCT02958566 2017-03-20
Multimodal Narcotic Limited Perioperative Pain Control With Colorectal Surgery
University of Illinois College of Medicine at Peoria
Phase 4 Unknown
NCT02687347 2016-09-20
UDOME
McGill University Health Centre/Research Institute of the McGill University Health Centre
Phase 3 Unknown
NCT00634010 2016-05-09
Morphine Versus Methadone As First Line Strong Opioid for Cancer Pain
M.D. Anderson Cancer Center
Phase 3 Terminated
NCT00558870 2016-04-05
Role of Methadone As Co-Opioid Analgesic
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT00573937 2016-02-19
Methadone Versus Morphine for Cancer-Related Pain
Mayo Clinic
Phase 2 Terminated
NCT01317589 2015-07-16
310111-4
Maastricht University Medical Center
Phase 4 Completed
NCT02335398 2015-01-09
Development and Evaluation of a Methadone Protocol for Severe Chronic Pain Management
Mahidol University
Phase 4 Completed
NCT00184496 2014-02-28
Switching From Morphine to Methadone. A Clinical, Pharmacological and Pharmacogenetic Study
Norwegian University of Science and Technology
Phase 3 Completed
NCT00525967 2007-09-06
Switching From Morphine to Oral Methadone Plus Acetaminophen in the Treatment of Cancer Pain
Faculdade de Medicina do ABC
Phase 2/3 Unknown